We observed a significant and consistent upregulation of FOXM1 in cancer cells, when compared to normal cells, across all three tumor microenvironments (p = 1.4 × 10−76 for BrCA, p = 1.0 ×10−92 for LuCA and p < 2.2 × 10−308 for CRCA. Here, FOXM1 is linked to neoplasm.